Fig. 5. TA shows dual function for NF-κB signaling depending on inflammatory status HCT116 cells (A, B) were treated with 0 or 50 μM of TA for 6 h or pre-treated for 6 h and then co-treated with TNF-α (10 ng/mL) for an additional 15 min. Western blotting was performed for antibodies against IκB-α, phospho-JNK, phospho-ERK, JNK, ERK and actin.
© Biomolecules & Therapeutics
